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Abstract
A new approach to the anticancer drug Velcade was developed by performing asymmetric borylation of an imine anchored with a
chiral N-phosphinyl auxiliary. Throughout the 7-step synthesis, especially in the imine’s synthesis and in the asymmetric boryla-
tion reactions, operations and work-up were conducted in simple and easy ways without any column chromatographic purification,
which defines the GAP (group-assisted purification) chemistry concept. It was found that the optically pure isomer (dr > 99:1) can
be readily obtained by washing the crude mixture of the asymmetric borylation reaction with hexane; the chiral N-phosphinyl auxil-
iary can be easily recovered after deprotection is finished. Several other N-phosphinylimines were also investigated for the asym-
metric borylation reaction. The absolute configuration of the borylation product was confirmed by single crystal X-ray diffraction
analysis.
Introduction
The synthesis of chiral α-aminoboronic acids and their deriva-
tives has attracted much attention in the organic and medicinal
chemistry communities because of their importance for drug
discovery and biological research [1-8]. In the past several
years, asymmetric catalysis and auxiliary-directed asymmetric
synthesis has been conducted for assembling adjacent chiral
centers of boronic aicds [9-13], but only a few methods for
generating chiral α-aminoboronic acids have been reported so
far [14-20]. Among the resulting products from the above
methods, (R)-(1-amino-3-methylbutyl)boronic acid served as
the key mechanism-based pharmacophore in the anticancer drug
Velcade, which was the first FDA approved proteasome
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Scheme 1: Previous work for (R)-(1-amino-3-methylbutyl)boronic acid synthesis.
inhibitor, and has been in clinical use for the treatment of
multiple myeloma and mantle cell lymphoma [21]. This prod-
uct is usually synthesized in three representative processes:
(1) to use (1S,2S,3R,5S)-(+)-2,3-pinanediol as the chiral auxil-
iary for the addition reaction followed by chlorination and
amination [14,15]; (2) to perform copper-catalyzed borylation
of the imine anchored with chiral auxiliaries [16,17]; (3) to con-
duct asymmetric catalytic hydrogenation as the key step to
control the chiral center of boronic aicd [18]. As anticipated, the
above known syntheses required traditional purification
methods using column chromatography or recrystallization
(Scheme 1).
Recently, our group has established a concept called GAP
(group-assisted purification) chemistry for greener synthesis
[22-25]. This concept describes a process where special func-
tional groups are attached onto reaction substrates, facilitating
purification of crude products by avoiding traditional purifica-
tion methods such as chromatography or recrystallization. The
pure products, often pure stereoisomers, can be easily obtained
by washing the crude products with common solvents or
co-solvents [22-25]. Our GAP concept was attributed to the
study of a series of new compounds containing achiral/chiral
N-phosphonyl and chiral N-phosphinylimines, and the reactions
of these compounds.
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Scheme 2: Synthesis of (R)-4 and Velcade.
The requirements of GAP chemistry are shown by the fact that
the functional groups of the reactants should generate products
of adequate solubility. The GAP products should be soluble in
some solvents such as THF and DCM for further reactions.
However, they should have poor solubility in other solvents
such as petroleum ether, hexanes, and their co-solvents with
EtOAc. The GAP requirements should include adequate chem-
ical reactivity of GAP compounds towards many reactants and
species. If GAP groups are chiral, they should control asym-
metric additions efficiently. Our GAP functional groups have
also showed the flexibility for structural modifications in order
to control the solubility of products and also to control the
chemical tolerance towards various reactions under different
conditions. Moreover, the GAP auxiliaries have been proven to
be easily deprotected under several conditions for re-use.
Herein, we report the synthesis of the anticancer drug Velcade
and its derivatives of chiral α-aminoboronic esters via GAP
chemistry. Simple operations are needed during purification
without the need for column chromatography; GAP washing
can lead to a single isomeric product, which was deprotected
with quantitative recovery of the phosphinic acid as shown in
Scheme 2.
Results and Discussion
We started our synthesis with (2S ,5S)-1-amino-2,5-
diphenylphospholane 1-oxide (1), which was synthesized
according to the literature and our previous work in 7 steps
from (1E,3E)-1,4-diphenylbuta-1,3-diene with an overall high
yield (27% for 7 steps) [25,26]. With the optically pure amide 1
in hand, we screened the condensation conditions to generate
the imine 2a. Titanates, such as Ti(OiPr)4 and Ti(OEt)4,
resulted in the complete conversion of the aliphatic aldehyde in
two days, but the hemiaminal was obtained as the main product
[27], which can slowly decompose to release the desired imine
2a. Anhydrous CuSO4, which was used as a mild condensation
reagent by Ellman’s group, was found to be not suitable for this
condensation reaction. This lack of suitability can probably be
attributed to the strong coordination tendency of the imine to a
copper ionic center. TiCl4 was proven to be an efficient reagent
and lead to complete condensation within 2 hours to give 90%
conversion to imine according to crude 31P NMR. We also
found that when the crude imine product was purified by
column chromatography, isomerization of 2a to enamine was
observed; this observation became more obvious when the
solvents used for chromatography contained a higher water
content. Eventually, MgSO4 or CaSO4 was chosen as the dehy-
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Figure 1: ORTEP diagram of (S,S,R)-3a (left, most of the hydrogen atoms were omitted except the one on the chiral center connected to boron) and
the H-bonds between the molecules (right). Selected bond lengths [Å] and angle [o]: P1–O1 1.505, P1–N1 1.613, N1–H1, 0.957, B1–O2 1.368, the
H-bond O1···H2 1.990; the angle of H bond N1–H1···O4 142.79.
dration reagent together with molecular sieves for imine forma-
tion. Under these conditions, complete conversion can be
reached after 5 days to give the chiral N-phosphinylimine,
which can be directly used for the following asymmetric boryla-
tion reaction without further purification.
B2Pin2 and ICyCuOt-Bu were utilized as the electrophilic addi-
tion reagent and catalyst, respectively, for the borylation reac-
tion as previously reported [16,28]. Unlike the previous system,
in which benzene was employed as the solvent, we used the
much less toxic solvent toluene to successfully replace benzene.
We achieved full conversion with 2 equiv of B2Pin2 in the pres-
ence of 20 mol % of ICyCuOt-Bu catalyst after 3 days to afford
a dr value of 7.7:1 as revealed by crude 31P NMR analysis.
After simple work-up and washing with hexanes, the dr value
was improved to a single isomer (Scheme 2) in 56% yield for
two steps. The absolute configuration of product 3a was unam-
biguously determined by X-ray analysis [29] to be in the
(S,S,R)-configuration (Figure 1). As shown in Figure 1,
H-bonds exist between the molecules, which would further help
the formation of the solid.
To hydrolyze the resulting aminoboronic ester, the known
method [16] was followed first by treating the ester with one
equivalent of HCl in co-solvents of methanol and dioxane. A
mixture of products was generated indicating a poor yield
according to the crude 31P and 1H NMR analysis. Another
co-solvent system consisting of H2O and MeOH (2:1) was
examined. It was found that treatment of the aminoboronic ester
with 1.5 equiv of HCl for 16 hours resulted in complete depro-
tection; work-up consisted of extraction with DCM followed by
concentration to give product 4 as a white solid in 92% yield.
Pure phosphinic acid 5 was recovered by simple filtration in
quantitative yield. The final product, Velcade 6, was synthe-
sized according to the literature procedure [16] in 83% yield
after 4 steps (Scheme 2). 1H NMR and 13C NMR spectra of the
product were proven to be identical to the literature data.
To expand the substrate scope for the borylation reaction,
several other new N-phosphinyl imines were synthesized for
examination (Scheme 3). Ti(OiPr)4 was chosen as the general
condensation reagent. When aliphatic aldehydes were subjected
to the condensation reaction, the main products were generated
either as hemiaminals 7 or as a mixture of imine and hemi-
aminal after purification by column chromatography. The hemi-
aminals were slowly transferred to the corresponding N-phos-
phinylimine as revealed by NMR analysis. The aliphatic imines
are found to be unstable even in the presence of a trace amount
of moisture, and can easily isomerize to form the enamine.
Therefore, we directly subjected the mixture of imine and hemi-
aminal to the borylation reaction. The borylation reactions went
smoothly with full conversion after stirring the reaction mix-
ture at room temperature for 3 days. Although moderate dia-
stereoselectivities were obtained for all the three aliphatic
N-phosphinylimines, the diastereopurities can be easily impro-
ved by GAP washing with hexane. For example, the original dr
value for 3b of 75:25 can be enhanced to a single isomer
(dr > 99:1) in 26% yield over two steps (calculated from amide
1). When aromatic aldehydes were employed, the yields of
N-phosphinylimine formations were quantitative; the crude
products were almost pure according to crude 31P NMR spectra.
After simple work-up to remove most of the titanate, the crude
products were used directly for the next step without further
purification. For the aromatic cases (entries 4 and 5, Table 1),
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Scheme 3: Synthesis of phosphinylimines and their borylation products.
Table 1: Results of borylation reactionsa.
Entry Imines R Products dr (crude)b dr (GAP)b Yieldc
1 2b iPr 3b 75:25 >99:1 26%
2 2c cyclohexyl 3c 78:22 99:1 40%
3 2d PhCH2CH2 3d 84:16 98:2 45%
4 2e Ph 3e 97:3 – 51%
5 2f 4-MeOPh 3f >99:1 – 44%
aReaction conditions: 0.74 mmol scale, [substrate] = 1.8 M, 2.0 equiv B2Pin2, 20 mol % ICyCuOt-Bu, toluene (4 mL), room temperature, 3 days.
bDetermined by 31P NMR analysis. cCalculated from the starting amide 1, isolated yields with GAP washing (for 3e and 3f, GAP washing was not
conducted).
excellent diastereoselectivities, dr = 97:3 and >99:1, respective-
ly, were achieved according to the 31P NMR analysis of crude
products. Pure products 3e and 3f were obtained via flash
column chromatography since GAP washing led to some
decomposition in these two cases.
Conclusion
We have successfully demonstrated that N-phosphinylimines
can undergo electrophilic borylation reactions, and that this
reaction can be applied in the synthesis of the anticancer drug
Velcade. The N-phosphinyl auxiliary displayed good to excel-
lent asymmetric induction and great stability in the catalytic
borylation and deprotection reactions. GAP washing is found to
enhance the diastereopurity of the borylation products in most
cases. The absolute configuration of the borylation product in
Velcade’s synthesis has been confirmed by single crystal X-ray
diffraction analysis.
Experimental
Standard operations for catalytic borylation and GAP: A 10 mL
Schlenk tube was charged with crude imine 2, B2Pin2 (375 mg,
2 equiv), catalyst ICyCuOt-Bu (54 mg, 20 mol %) and 4 Å
molecular sieves (~500 mg). The mixture was protected with
argon atmosphere, followed by toluene (4 mL) addition via
syringe. The reaction mixture was stirred vigorously for 3 days,
and the resulting slurry was filtered through Celite and washed
with EtOAc 5 times. The filtrate was then concentrated and
checked by 31P NMR to determine the % conversion and the
crude dr value. GAP operations: 1) Method A: The filtrate was
re-dissolved in EtOAc and washed with 1 N HCl, water, and
brine successively, then dried over anhydrous Na2SO4. The
crude product was obtained by filtration and concentration, fol-
lowed by addition of 5 mL of hexanes to triturate the crude
product. After 30 minutes, the solvent was decanted and another
5 mL hexanes were added. The resulting slurry was then filtered
and the solid was washed with another 2 mL hexanes. The solid
product was collected and dried in vacuo. The yield was calcu-
lated and the dr value and purity were checked by 31P NMR and
1H NMR. 2) Method B: The filtrate was re-dissolved in EtOAc/
hexanes (20 mL, v/v = 1:1), and then filtered through Celite.
The filtrate was concentrated and triturated with hexanes
(5 mL). After 30 minutes, the solvent was decanted and another
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5 mL hexanes was added. The resulting slurry was then filtered
and the solid was washed with another 2 mL hexanes. The solid
product was collected and dried in vacuo. The yield was calcu-
lated from the starting amide 1. The dr value and purity were
checked by 31P NMR and 1H NMR.
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